Guest guest Posted February 25, 2010 Report Share Posted February 25, 2010 [LDN_Users] Dr Mercola supporting LDN (again) Please read the attached link (you'll need to scroll down to see his comments http://www.mmshealthyforlife.com/?p=2162 Lots of other helpful information in this too. However, there are a few other newer treatments that are worth looking into as well, especially low-dose Naltrexone (LDN), along with alpha lipoic acid. 1. Low-Dose Naltrexone Naltrexone (generic name) is a pharmacologically active opioid antagonist, conventionally used to treat drug- and alcohol addiction -- normally at doses of 50mg to 300mg. As such, it's been an FDA-approved drug for over two decades. However, researchers have found that at very low dosages (3 to 4.5 mg), naltrexone has immunomodulating properties that may be able to successfully treat cancer malignancies and a wide range of autoimmune diseases like rheumatoid arthritis, multiple sclerosis, Parkinson's, fibromyalgia, and Crohn's disease, just to name a few. Dr. Bert Berkson is an expert on this regimen. For more information about his findings and successes using this combination, please review <http://articles.mercola.com/sites/articles/archive/2009/05/16/This-Antioxid ant-Can-Smash-Insulin-Resistance-and-Autoimmune-Disease.aspx> this previous article. Jayne Crocker www.LDNNow.com <http://www.ipetitions.com/petition/ldnnow/> Important! Please sign our LDN petition to the European Parliament by clicking here tel: +44 (0) 7877 492 669 < Dr Steele MBE, talking about LDN LDNNow, a patient and friend led organisation (so not a charity) with no funding and no affiliation to any company or organisation, but rather a group of concerned individuals focussed on improving the health of those who suffer from the many diseases and conditions that LDN treats. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.